Daily Dose of Methylphenidate: 10-60mg
Methylphenidate, or Ritalin, is a prescription drug that can help treat symptoms of attention deficit hyperactivity disorder in children and adults. Some of the symptoms for which it is used include difficulty focusing, inability to control actions, and difficulty keeping quiet or still. It is also used to treat symptoms of Narcolepsy, a sleep disorder that causes sudden sleepiness even during the day. It is classified as a psychostimulant drug which temporarily improves either mental or physical function, or even both. Examples of the effects of this type of drug include enhanced alertness and wakefulness. Methylphenidate works by changing substance amounts in the brain. More specifically, it increases the levels of the neurotransmitters dopamine and norepinephrine. Disorders like ADHD are linked to inadequate performance of these two neurotransmitters. They are responsible for self regulation and concentration functions of the brain.
Stimulants like Methylphenidate have been used illegally to aid in weight loss. Many people believe that they can use it for weight loss because it is a stronger stimulant than caffeine. Its potency as a stimulant falls in between caffeine and amphetamines. However, it is does not qualify as a weight loss drug and it can be very dangerous, especially at high doses. Using it for losing weight may even set you farther from your goal than when you started. Ritalin is a scheduled drug and if not controlled, it has a strong potential for abuse. Some of its serious side effect are fast pounding or uneven heartbeats, feeling like you might pass out, aggression, restlessness, bruising easily, and dangerously high blood pressure. Some of its less serious side effects include stomach pain, nausea, vomiting, vision problems, and dizziness. To avoid potential health risks, follow the directions on your prescription label carefully. The recommended dose for Ritalin is 1-60mg a day taken in 2-3 divided doses.
- Barragán E, Breuer D, Döpfner M. Efficacy and Safety of Omega-3/6 Fatty Acids, Methylphenidate, and a Combined Treatment in Children With ADHD. J Atten Disord. 2014 Jan 24. PMID: 24464327.
- Piñeiro-Dieguez B, Balanzá-Martínez V, García-García P, Soler-López B. Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study. J Atten Disord. 2014 Jan 24. PMID: 24464326.
- Takahashi N1, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. World J Biol Psychiatry. 2014 Jan 23. PMID: 24456065.